Thought Leader Select Lands New KOL Strategy Engagement in Diabetes
October 3, 2013 (CHAPEL HILL, NC) Thought Leader Select has accepted a new key opinion leader (KOL) strategy engagement with a global biopharmaceutical leader in the treatment area of diabetes. The client company, one of the world’s top five industry leaders in the development of medications for managing type I and type II diabetes, tabbed North …
Thought Leader Select Lands New KOL Strategy Engagement in Diabetes Read More »
